Health X Platform Limited has informed stock exchanges about another acquisition of additional equity shares by its promoter Mr. Banwari Lal Mittal. The company disclosed this latest transaction under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 on March 19, 2026.

Latest Share Acquisition Details

Mr. Banwari Lal Mittal, a promoter of Health X Platform Limited, acquired 7,663 equity shares through market purchase in his most recent transaction. The updated transaction details are presented below:

Updated Shareholding Pattern

The latest acquisition resulted in a further increase in Mr. Mittal's shareholding in the company. His current shareholding position reflects the cumulative effect of recent transactions:

Regulatory Compliance

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, submitted the latest disclosure to both BSE Limited and National Stock Exchange of India Limited. The company trades under stock code 533259 on BSE and symbol SASTASUNDR on NSE.

The disclosure was made in Form C as specified under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Compliance Officer Pratap Singh digitally signed the disclosure documents on March 19, 2026, on behalf of the company.

Company Information

Health X Platform Limited operates with CIN L65993WB1989PLC047002 and maintains its registered office at Azimganj House, 2nd Floor, 7, Abanindra Nath Thakur Sarani, Kolkata. The company's ISIN is INE019J01013, and it continues to operate under its healthcare and platform business model following its name change from Sastasundar Ventures Limited.

Health X Platform Limited has formally announced an analyst and investor meeting scheduled for March 19, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company, formerly known as sastasundar ventures Limited, communicated this development to both BSE Limited and National Stock Exchange of India Limited on March 16, 2026.

Meeting Details and Format

The analyst meeting will be conducted as an in-person group conference at Godrej BKC, Mumbai. The session is structured to accommodate investors and analysts through two one-hour slots within the designated timeframe.

Regulatory Compliance and Information Sharing

The company has emphasized strict adherence to regulatory guidelines during the investor interaction. Health X Platform Limited has explicitly stated that only information available in the public domain will be shared and discussed during the meeting. The company has committed to ensuring no unpublished price sensitive information will be disclosed during the analyst and investor interactions.

Communication and Accessibility

The meeting schedule has been communicated to relevant stock exchanges as required under Regulation 30 of SEBI Listing Regulations. The company has noted that the schedule may be subject to change due to exigencies on the part of analysts or investors. Additionally, the communication will be made available on multiple platforms including the company's website, BSE Limited's portal, and National Stock Exchange of India Limited's website for broader accessibility and transparency.

The announcement was signed by Pratap Singh, Company Secretary and Compliance Officer, ensuring proper corporate governance protocols are followed for this investor engagement initiative.